{
    "clinical_study": {
        "@rank": "151316", 
        "arm_group": {
            "arm_group_label": "Cohort 1", 
            "arm_group_type": "Experimental", 
            "description": "10 subjects with Plasmodium falciparum malaria will receive 75 mg KAE609 as a single dose"
        }, 
        "brief_summary": {
            "textblock": "This study will assess efficacy, safety , tolerability and PK in uncomplicated adult malaria\n      patients with acute P. falciparum infection after single dose with KAE609 at 75 mg/day"
        }, 
        "brief_title": "A Study to Assess Efficacy, Safety of KAE609 in Adult Patients With Acute Malaria Mono-infection", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Cure Rate", 
        "condition_browse": {
            "mesh_term": "Malaria, Falciparum"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male and female patients aged 20 to 60 years\n\n          -  Presence of mono-infection of P. falciparum\n\n          -  Weight between 40 kg to 90 kg\n\n        Exclusion Criteria:\n\n          -  Patients with signs and symptoms of severe/complicated malaria\n\n          -  Mixed Plasmodium infection\n\n          -  Presence of other serious or chronic clinical condition requiring hospitalization.\n\n          -  Severe malnutrition\n\n          -  Significant chronic medical conditions which in the opinion of the investigator\n             preclude enrollment into the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01860989", 
            "org_study_id": "CKAE609X2202"
        }, 
        "intervention": {
            "arm_group_label": "Cohort 1", 
            "description": "KAE609 75mg", 
            "intervention_name": "KAE609", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": "parasitemia", 
        "lastchanged_date": "April 3, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Taipei", 
                        "country": "Taiwan"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bangkok", 
                        "country": "Thailand", 
                        "zip": "10400"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ratchabari", 
                        "country": "Thailand", 
                        "zip": "70180"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Srisaket", 
                        "country": "Thailand", 
                        "zip": "33140"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Srisaket", 
                        "country": "Thailand", 
                        "zip": "33150"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tak", 
                        "country": "Thailand", 
                        "zip": "63110"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tak", 
                        "country": "Thailand", 
                        "zip": "63110"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tak", 
                        "country": "Thailand", 
                        "zip": "63140"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hanoi", 
                        "country": "Vietnam", 
                        "zip": "10000"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Taiwan", 
                "Thailand", 
                "Vietnam"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "An Open Label, Single Dose Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of KAE609 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum Malaria Mono-infection", 
        "overall_contact": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone": "+41613241111"
        }, 
        "overall_contact_backup": {
            "last_name": "Novartis Pharmaceuticals"
        }, 
        "overall_official": {
            "affiliation": "Novartis Pharmaceuticals", 
            "last_name": "Novartis Pharmaceuticals", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Thailand: Ministry of Public Health", 
                "Vietnam: Ministry of Health"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Parasite density in blood.", 
            "measure": "Complete cure rate without recrudescence at Day 29", 
            "safety_issue": "No", 
            "time_frame": "baseline to Day 29"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01860989"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Median parasite clearance times (PCT)", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }, 
            {
                "measure": "Fever clearance times (FCT)", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }
        ], 
        "source": "Novartis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novartis Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}